TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
25.71
+1.36 (5.59%)
At close: Oct 29, 2024, 4:00 PM
25.50
-0.21 (-0.82%)
After-hours: Oct 29, 2024, 7:25 PM EDT

TG Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 36.33, with a low estimate of 20 and a high estimate of 50. The average target predicts an increase of 41.31% from the current stock price of 25.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $20 $36.33 $40 $50
Change -22.21% +41.31% +55.58% +94.48%

Analyst Ratings

The average analyst rating for TGTX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 444445
Buy 111111
Hold 111111
Sell 000000
Strong Sell 000000
Total 666667

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
TD Cowen
TD Cowen
Strong Buy
Initiates
$50
Strong Buy Initiates $50 +94.48% Oct 29, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$49
Strong Buy Reiterates $49 +90.59% Sep 18, 2024
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$29$34
Strong Buy Maintains $29$34 +32.24% Aug 7, 2024
Goldman Sachs
Goldman Sachs
Hold
Maintains
$18$20
Hold Maintains $18$20 -22.21% Aug 7, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$49
Strong Buy Reiterates $49 +90.59% Aug 6, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
334.94M
from 233.66M
Increased by 43.34%
Revenue Next Year
505.05M
from 334.94M
Increased by 50.79%
EPS This Year
0.15
from 0.09
Increased by 68.54%
EPS Next Year
0.77
from 0.15
Increased by 411.86%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
152.00K152.00K6.69M2.79M233.66M334.94M505.05M719.19M
Revenue Growth
--4,300.66%-58.36%8,290.02%43.34%50.79%42.40%
EPS
-1.96-2.42-2.63-1.460.090.150.771.57
EPS Growth
-----68.54%411.86%103.75%
Forward PE
-----170.8933.3916.39
No. Analysts -----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 432.3M 603.7M 1.1B
Avg 334.9M 505.1M 719.2M
Low 301.1M 366.3M 444.6M

Revenue Growth

Revenue Growth 20242025202620272028
High
85.0%
80.2%
114.2%
Avg
43.3%
50.8%
42.4%
Low
28.9%
9.4%
-12.0%

EPS Forecast

EPS 20242025202620272028
High 0.61 1.11 3.31
Avg 0.15 0.77 1.57
Low -0.04 0.32 0.43

EPS Growth

EPS Growth 20242025202620272028
High
582.2%
639.8%
329.5%
Avg
68.5%
411.9%
103.8%
Low -
115.0%
-44.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.